Abstract
Preparation and application protocols play a very important role while optimizing the cationic lipid-based lipoplexes in vitro. These protocols serve as the basis for the betterment of the lipoplexes with regard to their successful application in animals and eventually human subjects. Starting from the chemical structures of used cationic lipids (CLs), optimization of the additive inclusions, methods of nanoparticle (lipoplex) formation, presence of blood serum, time intervals of lipoplex incubation, and type of efficiency read-outs in various conditions play important roles in reaching insightful conclusions. Such steps of summarizing protocols and requirements of the pertinent events focus on getting improved lipoplexes for achieving optimal effects in terms of post transfection gene and protein expression. The progression of optimization and efficiency evaluation lead to predictable structure-method-activity relationship with involvement of various feedback principles including physical chemical and biomolecular evaluations before and after the use of lipoplexes in biological systems. This chapter discusses some of the focused strategies for the establishment of lipoplexes for a better post transfection activity with reduced risk of failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
“Disease” at Dorland’s Medical Dictionary
“Mental Illness—Glossary”. US National Institute of Mental Health. Retrieved 18 Apr 2010
Anderson WF (1998) Human gene therapy. Nature 392:25–30
Hattori Y, Maitani Y (2005) Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 12:796–809
Chae HY, Lee BW, Oh SH, Ahn YR, Chung JH, Min YK, Lee MS, Lee MK, Kim KW (2005) Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice. Exp Mol Med 37:513–523
Yang Y, Nunes FA, Berencsi K, Goenczoel E, Engelhardt JF, Wilson JM (1994) Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 7:362–369
Curiel TJ, Piche A, Kasono K, Curiel DT (1997) Gene therapy strategies for AIDS-related malignancies. Gene Ther 4:1284–1288
Yla-Herttuala S, Martin JF (2000) Cardiovascular gene therapy. Lancet 355:|213–222
Vasir JK, Labhestwar V (2007) Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 59:718–728
Ow H, Larson DR, Srivastava M, Baird BA, Webb WW, Wiesner U (2005) Bright and stable core − shell fluorescent silica nanoparticles. Nano Lett 5:113–117
Jin S, Ye K (2007) Nanoparticle-mediated drug delivery and gene therapy. Biotechnol Prog 23:32–41
Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, He TC (2001) Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1:149–162
Anderson WF (1984) Prospects for human gene therapy. Science 226:401–409
Robbins PD, Tahara H, Ghivizzani SC (1998) Viral vectors for gene therapy. Trends Biotechnol 16:35–40
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84:7413–7417
Bhattacharya S, Bajaj A (2009) Advances in gene delivery through molecular design of cationic lipids. Chem Commun 31:4632–4656
Bhattacharya S, De S (1999) Synthesis and vesicle formation from dimeric pseudoglyceryl lipids with (CH2)m spacers: pronounced m‐value dependence of thermal properties, vesicle fusion, and cholesterol complexation. Chem Eur J 5:2335–2347
Dileep PV, Antony A, Bhattacharya S (2001) Incorporation of oxyethylene units between hydrocarbon chain and pseudoglyceryl backbone in cationic lipid potentiates gene transfection efficiency in the presence of serum. FEBS Lett 509:327–331
Bhattacharya S, Dileep PV (2004) Cationic oxyethylene lipids. Synthesis, aggregation, and transfection properties. Bioconjugate Chem 15:508–519
Gao X, Huang L (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochim Biophys Res Commun 179:280–285
Ghosh YK, Visweswariah SS, Bhattacharya S (2000) Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency. FEBS Lett 473:341–344
Hasegawa S, Hirashima N, Nakanishi M (2002) Comparative study of transfection efficiency of cationic cholesterols mediated by liposomes-based gene delivery. Bioorg Med Chem Lett 12:1299–1302
Nakanishi M (2003) Strategy in gene transfection by cationic transfection lipids with a cationic cholesterol. Curr Med Chem 10:1289–1296
Bajaj A, Mishra SK, Kondaiah P, Bhattacharya S (2008) Effect of the headgroup variation on the gene transfer properties of cholesterol based cationic lipids possessing ether linkage. Biochim Biophys Acta 1778:1222–1236
Bajaj A, Kondaiah P, Bhattacharya S (2008) Effect of the nature of the spacer on gene transfer efficacies of novel thiocholesterol derived gemini lipids in different cell lines: a structure–activity investigation. J Med Chem 51:2533–2540
Kumar K, Maiti B, Kondaiah P, Bhattacharya S (2015) Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids. Mol Pharm 12:351–361
Hirsch-Lerner D, Min Z, Eliyahu H, Ferrari ME, Wheeler CJ, Barenholz Y (2005) Effect of “helper lipid” on lipoplex electrostatics. Biochim Biophys Acta 1714:71–84
Kerner M, Meyuhas O, Hirsch-Lerner D, Rosen L, Min Z, Barenholz Y (2001) Interplay in lipoplexes between type of pDNA promoter and lipid composition determines transfection efficiency of human growth hormone in NIH3T3 cells in culture. Biochim Biophys Acta 1532:128–136
Simberg D, Danino D, Talmon Y, Minsky A, Ferrari M, Wheeler CJ, Barenholz Y (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J Biol Chem 276:47453–47459
Candiani G, Pezzoli D, Ciani L, Chiesa L, Ristori S (2010) Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action. PLoS One 5:e13430
Sarah R, Paul P, Alain TR (2009) Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacy. PLoS One 4:e6058
Hong K, Zheng W, Baker A, Papahadjopoulos D (1997) Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 400:233–237
Bhattacharya S, Mandal SS (1998) Evidence of interlipidic ion-pairing in anion induced DNA release from cationic amphiphile-DNA complexes. Mechanistic implications in transfection. Biochemistry 37:7764–7777
Misra SK, Biswas J, Kondaiah P, Bhattacharya S (2013) Gene transfection in high serum levels: case studies with new cholesterol based cationic gemini lipids. PLoS One 8:e68305
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Misra, S.K., Bhattacharya, S. (2016). Physical Chemical and Biomolecular Methods for the Optimization of Cationic Lipid-Based Lipoplexes In Vitro for the Gene Therapy Applications. In: Candiani, G. (eds) Non-Viral Gene Delivery Vectors. Methods in Molecular Biology, vol 1445. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3718-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3718-9_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3716-5
Online ISBN: 978-1-4939-3718-9
eBook Packages: Springer Protocols